NuVasive | NUVA - Marktkapitalisierung



Marktkapitalisierung Veränderung Datum
Abbott USD 217.86B 15.25B 2025-12
AtriCure USD 1.97B 215M 2025-12
Baxter International USD 9.82B 1.87B 2025-12
Becton, Dickinson and Co. USD 55.29B 1.64B 2025-12
Boston Scientific USD 141.35B 3.31B 2025-12
Cooper Companies USD 14.7B 1.24B 2026-03
Dexcom USD 25.88B 503M 2025-12
Edwards Lifesciences USD 49.47B 3.81B 2025-12
Globus Medical USD 12.64B 954M 2026-03
Haemonetics USD 3.76B 1.44B 2025-12
Hologic USD 16.62B 1.67B 2025-12
Insulet USD 20B 1.74B 2025-12
Integra LifeSciences USD 967M 150M 2025-12
Intuitive Surgical USD 200.77B 40.45B 2025-12
J&J USD 500.24B 67.44B 2025-12
Medtronic USD 105.26B 24.07B 2026-03
Merit Medical Systems USD 5.23B 297M 2025-12
Orthofix International USD 438M 166M 2026-03
Stryker USD 134.41B 6.92B 2025-12
Tandem Diabetes Care USD 1.49B 670M 2025-12
Teleflex USD 5.39B 91M 2025-12
Zimmer Biomet Holdings USD 17.82B 1.69B 2025-12